Nutrition for Transgender and Gender-diverse Individuals
PEN
® eNews is a monthly e-newsletter shared with the global PEN Community and created to help dietitians position themselves as leaders in evidence-based nutrition practice. In addition, users of the PEN System will find articles on the new evidence, resources and features available and how to maximize one's use of PEN.
New Knowledge Pathway Alert: Nutrition for Transgender and Gender-diverse Individuals
The latest knowledge pathway (KP) added to the PEN System is the Nutrition for Transgender and Gender-diverse Individuals KP. We expect this KP to expand as more research becomes available. Here is the current content:
Pediatric Intractable Epilepsy - Is a Ketogenic Diet an Effective Treatment?
The Question
What is the efficacy of following a ketogenic diet (classic, medium chain triglyceride, low glycemic index treatment or modified Atkins diet) in the treatment of pediatric intractable epilepsy?Recommendation
All types of ketogenic diets (classic, medium chain triglyceride (MCT), low glycemic index treatment (LGIT) and modified Atkins diet (MAD)) have been shown to reduce seizure frequency and improve the likelihood of achieving seizure freedom in children with intractable epilepsy.
The classic ketogenic diet (KD) and MAD have been studied most rigorously. The classic KD may have a larger effect than the MAD, while the MAD may have fewer side-effects. The MCT and LGIT are less well studied but appear efficacious, with the MCT having shown similar efficacy to the classic KD.
In infants <2 years, the classic KD has been recommended. Adolescents may do better with the MAD or LGIT, which are easier to follow and have better adherence.
Evidence Summary
A 2022 systematic review and meta-analysis of eight RCTs (n=453) found that children and adolescents with intractable epilepsy who followed a KD were more likely to reduce their seizure frequency by >50% than those who did not follow a KD. Only the classic KD and the MAD were examined.
A 2020 Cochrane review of 13 RCTs/quasi-RCTs (n=932) found that KDs could be effective in reducing seizures and achieving seizure freedom in children with intractable epilepsy, although the evidence is low or very low quality. Specifically, the classic KD and MAD showed potential efficacy, with a larger effect associated with the classic KD (seizure freedom in up to 55% of individuals compared to 25% for MAD, and reduced seizure frequency in up to 85% of individuals compared to 60% for MAD). However, fewer side-effects were associated with the MAD. Only one study compared the classic KD to the MCT, which found no significant differences in seizure reduction between the two diets. The LGIT was not examined in any included studies.
A 2018 expert consensus statement noted that the classic KD was most appropriate in children <2 years, while the MAD or LGIT were more appropriate in adolescents due to increased adherence. Although no studies have compared the LGIT to other ketogenic diets, it has shown promise in children with intractable epilepsy, especially those with Angleman syndrome. The MCT appears equivalent in efficacy to the classic KD while allowing for higher carbohydrate and protein intakes and a larger variety of food choices.
Grade of Evidence C
Remarks
The classic KD is defined as a diet with high lipid to non-lipid ratio. The MCT is defined as a diet with 60% of calories coming from MCT oil; alternatively, if this is not tolerated due to gastrointestinal side-effects, a lower dose of MCT oil (30-50% calories) may be used.
The MAD is a high fat, low carbohydrate diet focusing on fat and carbohydrate targets rather than ratios. The LGIT allows 45-60 grams of carbohydrate daily but requires that all carbohydrates have a glycemic index <50.
If a child requires a special dietary formulation, ketogenic liquid formula can be provided. Liquid diet formulations can be used in infants or in children with feeding tubes and have the benefit of increased compliance compared to whole food KDs.
See Additional Content: Nervous System – Pediatric/Paediatric Epilepsy: Ketogenic Diet Background.
To see the full practice question, including the Evidence Statements, Comments and References, click
here.
thank you to our PEN® volunteers
Our global PEN® partnership has benefited from volunteer efforts around the world. Please take a moment to read and acknowledge your colleagues who have served as authors, or peer reviewers for PEN content since December 2015, as well as the International Working Groups.
Australia
Chloe Angel
Jemma O’Hanlon
Kirsty Leray
South Africa
Kerry Pilditch
United Kingdom
Agnieszka Szmurlo
David Gray
Elaine Anderson
Elaine Lane
Holly Jeffreys
Maria Cazzulani
Megan Schoen
Ramona Lehadus
Sue Acreman
Canada
Anna Millman
Arundhati Joshi
Denise K. Daley
Denise Ridley
Edmond Chan
Emma Barr
Jacqueline Stickel
Jasna Robinson-Wright
Justine Keathley
Kim Arrey
Kristyn Hall
Marie-Claude Vohl
Melissa McDowell
Mun Cho
Nola Thompson
Ruth Harvie
Sally Willis-Stewart
Shée Lillejord
Stephanie Krug
Tanis Fenton
Trishtee Boojharut
Want to see your name amongst dietetics thought leaders from around the world? Become a PEN® author or reviewer! Please click here to send us your contact information.
PEN eNews
October 2023 Volume
13 (10)
A Publication of the PEN® System Global Partners,
a collaborative partnership between International Dietetic Associations.
Learn more about PEN.
Copyright Dietitians of Canada
. All Rights Reserved.